C MER Eye Care : GRANT OF SHARE OPTIONS UNDER THE SHARE OPTION SCHEME

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

C-MER EYE CARE HOLDINGS LIMITED

希 瑪 眼 科 醫 療 控 股 有 限 公 司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 3309)

GRANT OF SHARE OPTIONS UNDER THE SHARE OPTION SCHEME

This announcement is made pursuant to Rule 17.06A of the Rules Governing the Listing of Securities (the "Listing Rules") on The Stock Exchange of Hong Kong Limited (the "Stock Exchange").

The board (the "Board") of directors (the "Directors") of C-MER Eye Care Holdings Limited (the "Company" which together with its subsidiaries, the "Group") hereby announces that the Board has resolved to grant an aggregate of 1,140,000 share options (the "Share Options") to the executive director (the "Grantee") of the Company, Ms. LI Xiaoting on 14 September 2020 (the "Date of Grant"), to subscribe, in aggregate, for up to 1,140,000 ordinary shares (the "Shares" and each a "Share") of HK$0.1 each in the share capital of the Company subject to acceptance of the Grantee, under the share option scheme (the "Share Option Scheme") adopted by the Company on 13 December 2017.

Details of the Share Options granted are set forth below:

Date of Grant	: 14 September 2020
Exercise price	: HK$6.34 per Share, representing the highest of (i) the
	closing price of HK$6.34 per Share as stated in the daily
	quotations sheets issued by the Stock Exchange on the
	Date of Grant; (ii) the average closing price of HK$6.23
	per Share as stated in the daily quotation sheets issued by
	the Stock Exchange for the five business days immediately
	preceding the Date of Grant; and (iii) HK$0.1, being the
	nominal value of a Share

- 1 -

Number of Share Options	: 1,140,000 Share Options (each Share Option shall entitle
granted	the Grantee to subscribe for one Share)
Validity period of the Share	: The Share Options are valid and exercisable in whole or
Options	in parts during the period from the date of acceptance of
	the Share Options to three (3) years from Date of Grant
	and 100% of the Share Options will be vested on the first
	anniversary of the Date of Grant
Approximate % to issued	: 0.0997%
share capital of the
Company as at the date of
this announcement

If the Share Options are exercised in full and on the basis of 1,143,727,977 Shares in issue, the Shares to be issued by the Company pursuant to the exercise of the Share Options will represent approximately 0.1% of the enlarged number of the Shares in issue.

Under Rule 17.04(1) of the Listing Rules and the provision of the Share Option Scheme, each grant of Share Options to a Director, chief executive or substantial shareholder of the Company, or any of their respective associates, must be approved by the independent non- executive Directors. The grant of the Share Options to Ms. LI Xiaoting has been approved by all the independent non-executive Directors of the Company in a board meeting held on 28 August 2020.

By order of the Board

C-MER EYE CARE HOLDINGS LIMITED

Dr. LAM Shun Chiu Dennis

Chairman and Chief Executive Officer and Executive Director

Hong Kong, 14 September 2020

As of the date of this announcement, the Board comprises four executive Directors, namely Dr. LAM Shun Chiu Dennis, Ms. LI Xiaoting, Dr. LEE Yau Wing Vincent and Mr. LI Chunshan and four independent non-executive Directors, namely Dr. LI Kwok Tung Donald, Mr. MA Andrew Chiu Cheung, Mr. CHAN Chi Leong and Ms. BENTLEY Annie Liang.

- 2 -